The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis
Abstract
The histologic heterogeneity of lung adenocarcinoma creates a variety of complex challenges to pathologists in analyzing the various subtypes. Current classification schemas do not take into account the major subtype. We analyzed 100 cases for clinical, pathologic, and molecular features using a modification of the 2004 World Health Organization (WHO) classification to record the major component in the mixed subtype tumors. The tumors were analyzed for KRAS mutation and epidermal growth factor receptor (EGFR) by mutation, chromogenic in situ hybridization, and immunohistochemistry for EGFR and phosphorylated EGFR. Gene expression analysis was performed using HG-U133A Affymetrix oligonucleotide microarrays revealing 3 gene clusters. The most common major histologic subtype was papillary (37%) followed by acinar (30%), solid (25%) and bronchioloalveolar (7%) carcinoma (BAC), although no pure BACs were seen. Sixteen tumors harbored EGFR mutations and 14 KRAS mutations. Papillary adenocarcinoma strongly correlated with EGFR mutation (P<0.001) and gene profile Cluster 1 (P=0.006) with weaker correlations with low grade (P=0.038) and favorable behavior in Stage 1 patients (P=0.047). Micropapillary subtype correlated strongly with EGFR mutation (P<0.001) and weakly with Cluster 1 (P=0.030). Solid adenocarcinoma strongly correlated with gene profile Cluster 3 (P=0.001) and worse survival (P=0.001). BAC as a major component strongly correlated with gene Cluster 2 (P=0.001). Cluster 1 correlated strongly with less smoking (P<0.001), papillary histology (P<0.001), and EGFR mutations (P<0.001). Cluster 3 strongly correlated with heavier smoking (P<0.001), larger tumor size (P<0.001), solid subtype (P<0.001), and poor grade (P=0.004); weak correlations were found with KRAS mutation (P=0.025). No correlation was found with BAC and EGFR by mutation, chromogenic in situ hybridization or immunohistochemistry. Higher stage (P<0.001), grade (P<0.001), and solid subtype (P=0.001) correlated with shorter survival. Our data suggest that EGFR mutations are associated with papillary adenocarcinoma and gene profile Cluster 1. We discovered this only because we used a comprehensive approach examining in detail all histologic subtypes and we modified the 2004 WHO mixed subtype to include the major histologic subtype. As we do not know the major genetic pathways of 30% to 70% of lung adenocarcinomas, the comprehensive histologic subtyping we propose gives advantage for recognition of unanticipated histologic-genetic correlations that might not be detected using classification systems that focus primarily on specific aspects of adenocarcinomas such as BAC or EGFR mutations. Such an approach should be considered in future studies for validation in other datasets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
Potti, A., Mukherjee, S., Petersen, R., Dressman, H. K., Bild, A., Koontz, J., Kratzke, R., Watson, M. A., Kelley, M., Ginsburg, G. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060467 · Cited by 576
RetractedCluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527 · cited 2×
“In addition, some patients acquire resistance to tyrosine kinase inhibitors in association with specific mutations such as T790M.(38,58) Gene expression profiling using complementary DNA (cDNA) microarrays is another tool that has provided a new way to evaluate genetic abnormalities in lung carcinomas.”
BackgroundSelf-citationBhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Self-citationCappuzzo, F., Hirsch, F. R., Rossi, E., Bartolini, S., Ceresoli, G. L., Bemis, L., Haney, J., Witta, S., Danenberg, K., Domenichini, I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji112 · Cited by 1,551
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
Pao, W., Wang, T. Y., Riely, G. J., Miller, V. A., Pan, Q., Ladanyi, M., Zakowski, M. F., Heelan, R. T., Kris, M. G., & Varmus, H. E. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020017 · Cited by 1,516
Self-citationDiversity of gene expression in adenocarcinoma of the lung
Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241500798 · Cited by 1,298
Small adenocarcinoma of the lung. Histologic characteristics and prognosis
Noguchi, M., Morikawa, A., Kawasaki, M., Matsuno, Y., Yamada, T., Hirohashi, S., Kondo, H., & Shimosato, Y. (1995) · Cancer · doi:10.1002/1097-0142(19950615)75:12<2844::aid-cncr2820751209>3.0.co;2-# · Cited by 1,134
Mitsudomi, T., Kosaka, T., Endoh, H., Horio, Y., Hida, T., Mori, S., Hatooka, S., Shinoda, M., Takahashi, T., & Yatabe, Y. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.992 · Cited by 948
A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer
Chen, H.-Y., Yu, S.-L., Chen, C.-H., Chang, G.-C., Chen, C.-Y., Yuan, A., Cheng, C.-L., Wang, C.-H., Terng, H.-J., Kao, S.-F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060096 · Cited by 935
Glinsky, G. V., Berezovska, O., & Glinskii, A. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23412 · Cited by 916
Gordon, G. J., Jensen, R. V., Hsiao, L.-L., Gullans, S. R., Blumenstock, J. E., Ramaswamy, S., Richards, W. G., Sugarbaker, D. J., & Bueno, R. (2002) · PubMed · Cited by 859
Devesa, S. S., Bray, F., Vizcaino, A. P., & Parkin, D. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21183 · Cited by 745
Riely, G. J., Pao, W., Pham, D., Li, A. R., Rizvi, N., Venkatraman, E. S., Zakowski, M. F., Kris, M. G., Ladanyi, M., & Miller, V. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1846 · Cited by 731
Self-citationMiller, V. A., Kris, M. G., Shah, N., Patel, J., Azzoli, C., Gomez, J., Krug, L. M., Pao, W., Rizvi, N., Pizzo, B., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.158 · Cited by 730
Self-citationCritical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer
Baselga, J., & Arteaga, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.890 · Cited by 725
Takano, T., Ohe, Y., Sakamoto, H., Tsuta, K., Matsuno, Y., Tateishi, U., Yamamoto, S., Nokihara, H., Yamamoto, N., Sekine, I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.0793 · Cited by 695
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
Shigematsu, H., & Gazdar, A. F. (2006) · International Journal of Cancer · doi:10.1002/ijc.21496 · Cited by 657
Bell, D. W., Lynch, T. J., Haserlat, S. M., Harris, P. L., Okimoto, R. A., Brannigan, B. W., Sgroi, D. C., Muir, B., Riemenschneider, M. J., Iacona, R. B., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7078 · Cited by 601
Self-citationJackman, D. M., Yeap, B. Y., Sequist, L. V., Lindeman, N., Holmes, A. J., Joshi, V. A., Bell, D. W., Huberman, M. S., Halmos, B., Rabin, M. S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0462 · Cited by 584
Holzbeierlein, J., Lal, P., LaTulippe, E., Smith, A., Satagopan, J., Zhang, L., Ryan, C., Smith, S., Scher, H., Scardino, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63112-4 · Cited by 577
Self-citationHirsch, F. R., Varella-Garcia, M., McCoy, J., West, H., Xavier, A. C., Gumerlock, P., Bunn, P. A., Franklin, W. A., Crowley, J., & Gandara, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.2823 · Cited by 574
Takeuchi, T., Tomida, S., Yatabe, Y., Kosaka, T., Osada, H., Yanagisawa, K., Mitsudomi, T., & Takahashi, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8224 · Cited by 355
Chou, T.-Y., Chiu, C.-H., Li, L.-H., Hsiao, C.-Y., Tzen, C.-Y., Chang, K.-T., Chen, Y.-M., Perng, R.-P., Tsai, S.-F., & Tsai, C.-M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1981 · Cited by 317
Kikuchi, T., Daigo, Y., Katagiri, T., Tsunoda, T., Okada, K., Kakiuchi, S., Zembutsu, H., Furukawa, Y., Kawamura, M., Kobayashi, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206288 · Cited by 317
Travis, W. D., Garg, K., Franklin, W. A., Wistuba, I. I., Sabloff, B., Noguchi, M., Kakinuma, R., Zakowski, M., Ginsberg, M., Padera, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.15.776 · Cited by 288
Self-citationMolecular profiling of non-small cell lung cancer and correlation with disease-free survival.
Wigle, D. A., Jurišica, I., Radulovich, N., Pintilie, M., Rossant, J., Liu, G., Lu, C., Woodgett, J. R., Seiden, I., Johnston, M., et al. (2002) · PubMed · Cited by 276
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features
Barsky, S. H., Cameron, R., Osann, K. E., Tomita, D., & Carmack Holmes, E. (1994) · Cancer · doi:10.1002/1097-0142(19940215)73:4<1163::aid-cncr2820730407>3.0.co;2-j · Cited by 260
EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma
Yatabe, Y., Kosaka, T., Takahashi, T., & Mitsudomi, T. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000157935.28066.35 · Cited by 237
Detection of EGFR Gene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay
Asano, H., Toyooka, S., Tokumo, M., Ichimura, K., Aoe, K., Ito, S., Tsukuda, K., Ouchida, M., Aoe, M., Katayama, H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0934 · Cited by 189
CT Findings and Progression of Small Peripheral Lung Neoplasms Having a Replacement Growth Pattern
Takashima, S., Maruyama, Y., Hasegawa, M., Yamanda, T., Honda, T., Kadoya, M., & Sone, S. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.180.3.1800817 · Cited by 174
Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors
Khanna, M., Park, P., Zirvi, M., Cao, W., Picon, A., Day, J., Paty, P., & Barany, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202291 · Cited by 168
Terasaki, H., Niki, T., Matsuno, Y., Yamada, T., Maeshima, A., Asamura, H., Hayabuchi, N., & Hirohashi, S. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200307000-00009 · Cited by 167
Sequist, L. V., Joshi, V. A., Jänne, P. A., Muzikansky, A., Fidias, P., Meyerson, M., Haber, D. A., Kucherlapati, R., Johnson, B. E., & Lynch, T. J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-1-90 · Cited by 162
Miura, K., Bowman, E. D., Simon, R., Peng, A. C., Robles, A. I., Jones, R. T., Katagiri, T., He, P., Mizukami, H., Charboneau, L., et al. (2002) · PubMed · Cited by 158
c‐Met activation in lung adenocarcinoma tissues: An immunohistochemical analysis
Nakamura, Y., Niki, T., Goto, A., Morikawa, T., Miyazawa, K., Nakajima, J., & Fukayama, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00493.x · Cited by 145
Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer
Tsao, A. S., Tang, X., Sabloff, B. S., Xiao, L., Shigematsu, H., Roth, J. A., Spitz, M. R., Hong, W. K., Gazdar, A. F., & Wistuba, I. I. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31573-2 · Cited by 132
Sakamoto, H., Shimizu, J., Horio, Y., Ueda, R., Takahashi, T., Mitsudomi, T., & Yatabe, Y. (2007) · The Journal of Pathology · doi:10.1002/path.2165 · Cited by 129
Suzuki, M., Shigematsu, H., Iizasa, T., Hiroshima, K., Nakatani, Y., Minna, J. D., Gazdar, A. F., & Fujisawa, T. (2006) · Cancer · doi:10.1002/cncr.21853 · Cited by 127
Hsieh, R.-K., Lim, K., Kuo, H.-T., Tzen, C., & Huang, M.-J. (2005) · CHEST Journal · doi:10.1378/chest.128.1.317 · Cited by 120
Yoshida, Y., Shibata, T., Kokubu, A., Tsuta, K., Matsuno, Y., Kanai, Y., Asamura, H., Tsuchiya, R., & Hirohashi, S. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.04.012 · Cited by 117
Shibata, T., Uryu, S., Kokubu, A., Hosoda, F., Ohki, M., Sakiyama, T., Matsuno, Y., Tsuchiya, R., Kanai, Y., Kondo, T., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0293 · Cited by 104
True Papillary Carcinoma of the Lung: A Distinct Clinicopathologic Entity
Silver, S. A., & Askin, F. B. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199701000-00005 · Cited by 99
Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray
Kikuchi, T., Daigo, Y., Ishikawa, N., Katagiri, T., Tsunoda, T., Yoshida, S., & Nakamura, Y. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.4.799 · Cited by 68
Riquet, M., Foucault, C., Berna, P., Assouad, J., Dujon, A., & Danel, C. J. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.01.021 · Cited by 66
Haneda, H., Sasaki, H., Lindeman, N. I., Kawano, O., Endo, K., Suzuki, E., Shimizu, S., Yukiue, H., Kobayashi, Y., Yano, M., et al. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi228 · Cited by 66
Kim, Y. H., Ishii, G., Goto, K., Nagai, K., Tsuta, K., Shiono, S., Nitadori, J., Kodama, T., Nishiwaki, Y., & Ochiai, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0811 · Cited by 65
Bangur, C. S., Switzer, A., Fan, L.-Q., Marton, M. J., Meyer, M. R., & Wang, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205480 · Cited by 65
Xi, L., Lyons‐Weiler, J., Coello, M. C., Huang, X., Gooding, W. E., Luketich, J. D., & Godfrey, T. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2525 · Cited by 59
Daniele, L., Macrì, L., Schena, M., Dongiovanni, D., Bonello, L., Armando, E., Ciuffreda, L., Bertetto, O., Bussolati, G., & Sapino, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0719 · Cited by 56
McDoniels-Silvers, A. L., Stonert, G. D., Lubett, R. A., & You, M. (2002) · Neoplasia · doi:10.1038/sj.neo.7900217 · Cited by 50
Haneda, H., Sasaki, H., Shimizu, S., Endo, K., Suzuki, E., Yukiue, H., Kobayashi, Y., Yano, M., & Fujii, Y. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.12.005 · Cited by 47
Choi, J. S., Zheng, L. T., Ha, E., Lim, Y. J., Kim, Y. H., Wang, Y.-P., & Lim, Y. (2006) · Lung · doi:10.1007/s00408-006-0009-0 · Cited by 46
Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma
Matsumoto, S., Iwakawa, R., Kohno, T., Suzuki, K., Matsuno, Y., Yamamoto, S., Noguchi, M., Shimizu, E., & Yokota, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21670 · Cited by 46
Blackhall, F. H., Wigle, D. A., Jurišica, I., Pintilie, M., Liu, G., Darling, G. E., Johnston, M. R., Keshavjee, S. H., Waddell, T. K., Winton, T. L., et al. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.04.002 · Cited by 44
Ohtsuka, K., Ohnishi, H., Furuyashiki, G., Nogami, H., Koshiishi, Y., Ooide, A., Matsushima, S., Watanabe, T., & Goya, T. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30407-x · Cited by 43
Sun, Z., Yang, P., Aubry, M.-C., Kosari, F., Endo, C., Molina, J. R., & Vasmatzis, G. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-35 · Cited by 35
Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung
Sakuma, Y., Matsukuma, S., Yoshihara, M., Nakamura, Y., Nakayama, H., Kameda, Y., Tsuchiya, E., & Miyagi, Y. (2007) · Modern Pathology · doi:10.1038/modpathol.3800929 · Cited by 33
Nakamura, N., Iijima, T., Mase, K., Furuya, S., Kano, J., Morishita, Y., & Noguchi, M. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02207.x · Cited by 31
Takada, M., Tada, M., Tamoto, E., Kawakami, A., Murakawa, K., Shindoh, G., Teramoto, K., Matsunaga, A., Komuro, K., Kanai, M., et al. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.06.002 · Cited by 31
Ohnishi, H., Ohtsuka, K., Ooide, A., Matsushima, S., Goya, T., & Watanabe, T. (2006) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200606000-00007 · Cited by 29
Cited by
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Self-citationSomatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Self-citationNew driver mutations in non-small-cell lung cancer
Pao, W., & Girard, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70087-5 · Cited by 1,128
Yoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Self-citationEGFR Mutations and Lung Cancer
da Cunha Santos, G., Shepherd, F. A., & Tsao, M. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130206 · Cited by 949
Metadata
- Authors
- Motoi, N., Szoke, J., Riely, G. J., Seshan, V. E., Kris, M. G., Rusch, V. W., Gerald, W. L., & Travis, W. D.
- Venue
- American Journal of Surgical Pathology
- Published
- 2008-06
- Volume
- 32
- Issue
- 6
- Pages
- 810-827
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2076734146
- Cited by
- 371
- References
- 67
- FWCI
- 35.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.